Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Surprising Interactions Uncovered Between Diabetes and Sepsis

By HospiMedica International staff writers
Posted on 05 Mar 2009
Patients suffering from diabetes mellitus (DM) are less likely to suffer from acute lung injury (ALI) during severe sepsis, according to a new long-term study.

Researchers from Emory University (Atlanta, GA, USA) conducted a study that cross-referenced sepsis data from the U.S. More...
National Hospital Discharge Survey with DM prevalence data from the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA) Diabetes Surveillance System, A total of 930 million hospitalizations between 1979 and 2003 were analyzed. The researchers found that among patients with a respiratory source of sepsis, 16% of those with DM developed acute respiratory failure, compared with 23% in people without DM. Among patients with a nonpulmonary source of sepsis, those with DM were still less likely to develop acute respiratory failure when compared with those without DM (6% versus 10%). The researchers speculated that one of the possible mechanisms of protection in patients with DM may be impaired neutrophil function or altered neutrophil-endothelial interactions. Alternatively, patients with DM may be hospitalized earlier in the course of their illness than those with no DM because they learn to be aware of specific signs of infection. Pharmacological aspects of DM care could also influence the development of organ dysfunction, since many medications administered to patients with DM, including insulin and thiazolidinediones, are known to have anti-inflammatory effects, in addition to lowering blood glucose. The study was published online on February 13, 2009, in Critical Care, a publication of BioMed Central.

"We've found that people with DM and sepsis were more likely to develop acute renal failure than people without DM, while being less likely to develop acute respiratory failure,” said lead author Greg Martin, M.D. "Findings like these are important, as accurate identification of populations at risk for different acute organ dysfunctions is crucial to the development of novel therapies for these patients.”

Related Links:

Emory University
U.S. Centers for Disease Control and Prevention



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Emergency Ventilator
Shangrila935
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.